Feedback / Questions
lysergic acid diethylamide (MM-120) - Mindmed, University Hospital Basel
https://www.businesswire.com/news/home/20250414503827/en/MindMed-Announces-First-Patient-Dosed-in-Phase-3-Emerge-Study-of-MM120-in-Major-Depressive-Disorder-MDD
Apr 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next